Feifei Li

Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1

Xianglin Shi, Jia Luo, Xin Wang, 2012, Breast Cancer Research and Treatment.

Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer

Feifei Li, Sheng Liu, 2022, Frontiers in Immunology.

Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial -mesenchymal transition

Yi Ding, H. Fang, Yu Jiang, 2017, Cancer biology & therapy.

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1

Dabing Huang, Wei Wei, Leisheng Zhang, 2022, Frontiers in Oncology.

Combination of a novel microtubule inhibitor MBRI-001 and gemcitabine synergistically induces cell apoptosis by increasing DNA damage in pancreatic cancer cell lines

Xin Wang, Jinbo Yang, Ruochen Zang, 2019, Investigational New Drugs.

Role of RUNX2 in breast cancer development and drug resistance (Review)

Leisheng Zhang, Feifei Li, Chen Kan, 2023, Oncology letters.

Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment.

N. Zhang, Feifei Li, 2015, Current drug metabolism.